Shares of Dolby Laboratories (NYSE:DLB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six research firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $95.75.
Several research analysts have recently weighed in on the company. Rosenblatt Securities reaffirmed a "buy" rating and set a $95.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 1st. Barrington Research reaffirmed an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a research report on Friday, September 12th. Wall Street Zen raised Dolby Laboratories from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Tigress Financial upped their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Finally, Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a "neutral" rating and a $74.00 price objective for the company.
Read Our Latest Report on Dolby Laboratories
Dolby Laboratories Trading Down 0.3%
NYSE DLB opened at $67.38 on Friday. The stock has a 50-day simple moving average of $71.40 and a 200 day simple moving average of $73.53. The company has a market capitalization of $6.46 billion, a PE ratio of 24.68 and a beta of 0.92. Dolby Laboratories has a 12 month low of $66.96 and a 12 month high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm had revenue of $315.55 million during the quarter, compared to analysts' expectations of $305.23 million. During the same period in the previous year, the firm earned $0.71 earnings per share. The company's revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. As a group, sell-side analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 2.0%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is presently 48.35%.
Insider Activity
In related news, CEO Kevin J. Yeaman sold 25,000 shares of the company's stock in a transaction dated Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the sale, the chief executive officer owned 114,725 shares in the company, valued at approximately $7,901,110.75. This represents a 17.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the sale, the senior vice president owned 70,435 shares in the company, valued at $5,276,990.20. The trade was a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 82,000 shares of company stock worth $5,845,440 in the last quarter. 38.39% of the stock is currently owned by corporate insiders.
Institutional Trading of Dolby Laboratories
Institutional investors and hedge funds have recently bought and sold shares of the business. Securian Asset Management Inc. increased its stake in shares of Dolby Laboratories by 3.0% during the first quarter. Securian Asset Management Inc. now owns 4,648 shares of the electronics maker's stock worth $373,000 after purchasing an additional 137 shares during the period. Boothbay Fund Management LLC increased its stake in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker's stock worth $299,000 after purchasing an additional 157 shares during the period. MAI Capital Management increased its stake in shares of Dolby Laboratories by 87.1% during the first quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after purchasing an additional 162 shares during the period. Mitchell & Pahl Private Wealth LLC increased its stake in shares of Dolby Laboratories by 1.1% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker's stock worth $1,139,000 after purchasing an additional 170 shares during the period. Finally, Equitable Trust Co. increased its stake in shares of Dolby Laboratories by 3.3% during the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker's stock worth $413,000 after purchasing an additional 177 shares during the period. Institutional investors own 58.56% of the company's stock.
About Dolby Laboratories
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.